Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients

H Bourteel
December 2009
Journal of Neurology, Neurosurgery & Psychiatry;Dec2009, Vol. 80 Issue 12, p1405
Academic Journal
BACKGROUND: Limb-girdle muscular dystrophy 2I (LGMD2I) is caused by mutations in the fukutin-related protein gene FKRP, which is also involved in congenital muscular dystrophy (MDC1C). OBJECTIVE: To evaluate the clinical, biological, radiological and mutational characteristics of LGMD2I patients with FKRP mutation. METHODS: Eleven patients from nine families from the north of France were studied. Demographical data, muscular testing results, cardiac and respiratory examinations, muscle histological features and a genetic analysis of the FKRP gene for each patient are reported. Eight patients underwent brain MRI and seven neuropsychological tests. RESULTS: The patients included six women and five men. The mean age at onset was 9 years (range 1.5 to 23 years). Five patients remained self-ambulatory, whereas the other six were confined to a wheelchair by a mean age of 19 years, after a mean disease duration of 10 years. Nine patients suffered from restrictive respiratory insufficiency, and two male patients had severe dilated cardiomyopathy. Neuropsychological tests revealed memory impairment in four cases. Brain MRI revealed cerebral abnormalities in four patients (4/8). Ten patients were carriers of the common L276I mutation, which was either homozygous (four patients) or heteroallelic with another mutation (six patients). Among the mutations found, three were novel: L322V, L489R and R275G. CONCLUSIONS: This study reveals inter- and intrafamilial phenotypic variability in LGMD2I, with a preponderance of myocardiopathy and restrictive respiratory insufficiency. It also demonstrates central nervous involvement, probably associated with changes in α-dystroglycan expression in the brain.


Related Articles

  • Meta-analysis of clinical characteristics of 299 carriers ofLMNAgene mutations: do lamin A/C mutations portend a high risk of sudden death? van Berlo, Jop H.; de Voogt, Willem G.; van der Kooi, Anneke J.; van Tintelen, J. Peter; Bonne, Gisèle; Yaou, Rabah Ben; Duboc, Denis; Rossenbacker, Tom; Heidbüchel, Hein; de Visser, Marianne; Crijns, Harry J. G. M.; Pinto, Yigal M. // Journal of Molecular Medicine;Jan2005, Vol. 83 Issue 1, p79 

    This study evaluated common clinical characteristics of patients with lamin A/C gene mutations that cause either isolated dilated cardiomyopathy or dilated cardiomyopathy in association with skeletal muscular dystrophy. We pooled clinical data of all published carriers of lamin A/C gene...

  • δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches. Blain, Alison M.; Straub, Volker W. // Skeletal Muscle;2011, Vol. 1 Issue 1, p1 

    Mutations in the δ-sarcoglycan gene cause limb-girdle muscular dystrophy 2F (LGMD2F), an autosomal recessive disease that causes progressive weakness and wasting of the proximal limb muscles and often has cardiac involvement. Here we review the clinical implications of LGMD2F and discuss the...

  • Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins. Lewis, Caroline; Jockusch, Harald; Ohlendieck, Kay // Journal of Biomedicine & Biotechnology;2010, p1 

    Although Duchenne muscular dystrophy is primarily classified as a neuromuscular disease, cardiac complications play an important role in the course of this X-linked inherited disorder. The pathobiochemical steps causing a progressive decline in the dystrophic heart are not well understood. We...

  • Dystrophin Is Required for the Normal Function of the Cardio-Protective KATP Channel in Cardiomyocytes. Graciotti, Laura; Becker, Jodi; Granata, Anna Luisa; Procopio, Antonio Domenico; Tessarollo, Lino; Fulgenzi, Gianluca // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Duchenne and Becker muscular dystrophy patients often develop a cardiomyopathy for which the pathogenesis is still unknown. We have employed the murine animal model of Duchenne muscular dystrophy (mdx), which develops a cardiomyopathy that includes some characteristics of the human disease, to...

  • Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. Lammerding, Jan; Schulze, P. Christian; Takahashi, Tomosaburo; Kozlov, Serguei; Sullivan, Teresa; Kamm, Roger D.; Stewart, Colin L.; Lee, Richard T. // Journal of Clinical Investigation;Feb2004, Vol. 113 Issue 3, p370 

    Mutations in the lamin A/C gene (LMNA) cause a variety of human diseases including Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy, and Hutchinson-Gilford progeria syndrome. The tissue-specific effects of lamin mutations are unclear, in part because the function of lamin A/C is...

  • Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Moghadaszadeh, Behzad; Petit, Nathalie; Jaillard, Céline; Brockington, Martin; Roy, Susana Quijano; Merlini, Luciano; Romero, Norma; Estournet, Brigitte; Desguerre, Isabelle; Chaigne, Denys; Muntoni, Francesco; Topaloglu, Haluk; Guicheney, Pascale // Nature Genetics;Sep2001, Vol. 29 Issue 1, p17 

    One form of congenital muscular dystrophy, rigid spine syndrome (MIM 602771), is a rare neuromuscular disorder characterized by early rigidity of the spine and respiratory insufficiency. A locus on 1p35-36 (RSMD1) was recently found to segregate with rigid spine muscular dystrophy 1 (ref. 1)....

  • Neuromuscular disorders: Turning up the heat (shock). Tse, Man Tsuey // Nature Reviews Drug Discovery;May2012, Vol. 11 Issue 5, p354 

    A review of the article "Hsp72 Preserves Muscle Function and Slows Progression of Severe Muscular Dystrophy," by S.M. Gehrig, which appeared in the periodical "Nature" on April 4, 2012, is presented.

  • Muscular dystrophy. Blitchington, Rosemarie // WE Magazine;Mar/Apr99, Vol. 3 Issue 2, p27 

    Focuses on muscular dystrophy (MD). Prospects for the use of viruses in treating MD; Neuromuscular diseases under MD; Causes of MD; Breakthroughs in MD research.

  • Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Bittner, Reginald E.; Anderson, Louise V.B.; Burkhardt, Elke; Bashir, Rumaisa; Vafiadaki, Elizabeth; Ivanova, Silva; Raffelsberger, Thomas; Maerk, Isabel; Höger, Harald; Jung, Martin; Karbasiyan, Mohsen; Storch, Maria; Lassmann, Hans; Moss, Jennifer A.; Davison, Keith; Harrison, Ruth; Bushby, Kate M.D.; Reis, André // Nature Genetics;Oct99, Vol. 23 Issue 2, p141 

    Focuses on the dysferlin deletion in mice defining a natural model for limb girdle muscular dystrophy. Histopathological examinations of muscles in the mice of different ages and sources disclosing features compatible with a progressive muscular dystrophy; Dystrophic and inflammatory changes in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics